216 related articles for article (PubMed ID: 28600495)
1. Functional dissection of human targets for KSHV-encoded miRNAs using network analysis.
Wang Y; Lin Y; Guo Y; Pu X; Li M
Sci Rep; 2017 Jun; 7(1):3159. PubMed ID: 28600495
[TBL] [Abstract][Full Text] [Related]
2. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
[TBL] [Abstract][Full Text] [Related]
3. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.
Chen M; Sun F; Han L; Qu Z
Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260
[TBL] [Abstract][Full Text] [Related]
5. microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.
Sethuraman S; Gay LA; Jain V; Haecker I; Renne R
PLoS Pathog; 2017 Jul; 13(7):e1006508. PubMed ID: 28715488
[TBL] [Abstract][Full Text] [Related]
6. miRNAs and their roles in KSHV pathogenesis.
Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
[TBL] [Abstract][Full Text] [Related]
7. Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis.
Gallaher AM; Das S; Xiao Z; Andresson T; Kieffer-Kwon P; Happel C; Ziegelbauer J
PLoS Pathog; 2013; 9(9):e1003584. PubMed ID: 24039573
[TBL] [Abstract][Full Text] [Related]
8. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection.
Serquiña AKP; Kambach DM; Sarker O; Ziegelbauer JM
mBio; 2017 Jul; 8(4):. PubMed ID: 28698273
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.
Cai X; Lu S; Zhang Z; Gonzalez CM; Damania B; Cullen BR
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5570-5. PubMed ID: 15800047
[TBL] [Abstract][Full Text] [Related]
10. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
11. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
12. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
13. Identification of cellular genes targeted by KSHV-encoded microRNAs.
Samols MA; Skalsky RL; Maldonado AM; Riva A; Lopez MC; Baker HV; Renne R
PLoS Pathog; 2007 May; 3(5):e65. PubMed ID: 17500590
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro-angiogenic cytokine secretion in endothelial cells.
Guo Y; Li W; Qin J; Lu C; Fan W
J Med Virol; 2017 Jul; 89(7):1274-1280. PubMed ID: 28165144
[TBL] [Abstract][Full Text] [Related]
15. Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
Viollet C; Davis DA; Reczko M; Ziegelbauer JM; Pezzella F; Ragoussis J; Yarchoan R
PLoS One; 2015; 10(5):e0126439. PubMed ID: 25942495
[TBL] [Abstract][Full Text] [Related]
16. miRNA Sequence Analysis in Patients With Kaposi's Sarcoma-Associated Herpesvirus.
Tuncer SB; Celik B; Akdeniz Odemis D; Kılıc Erciyas S; Sukruoglu Erdogan O; Avsar M; Kuru Turkcan G; Yazici H
Pathol Oncol Res; 2022; 28():1610055. PubMed ID: 35140551
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.
Cai Q; Verma SC; Lu J; Robertson ES
Adv Virus Res; 2010; 78():87-142. PubMed ID: 21040832
[TBL] [Abstract][Full Text] [Related]
18. The Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Encodes a Mimic of the Tumor-Suppressive miR-15/16 miRNA Family.
Morrison K; Manzano M; Chung K; Schipma MJ; Bartom ET; Gottwein E
Cell Rep; 2019 Dec; 29(10):2961-2969.e6. PubMed ID: 31801064
[TBL] [Abstract][Full Text] [Related]
19. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus.
Conrad NK
Adv Appl Microbiol; 2009; 68():241-61. PubMed ID: 19426857
[TBL] [Abstract][Full Text] [Related]
20. Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.
Chugh PE; Sin SH; Ozgur S; Henry DH; Menezes P; Griffith J; Eron JJ; Damania B; Dittmer DP
PLoS Pathog; 2013; 9(7):e1003484. PubMed ID: 23874201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
